Lisofylline Sensitizes p53 Mutant Human Ovarian Carcinoma Cells to the Cytotoxic Effects ofcis-Diamminedichloroplatinum(II)
- 1 July 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 70 (1) , 17-22
- https://doi.org/10.1006/gyno.1998.4972
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assayPublished by Elsevier ,2002
- Aberrations of the p53 Tumor Suppressor Gene in Human Epithelial Ovarian CarcinomaGynecologic Oncology, 1995
- Efficient lipid-mediated transfection of DNA into primary rat hepatocytesIn Vitro Cellular & Developmental Biology – Animal, 1995
- Cell cycle control and cancer chemotherapyJournal of Cellular Biochemistry, 1994
- Chapter 25 Light Scatter of Isolated Cell Nuclei as a Parameter Discriminating the Cell-Cycle SubcompartmentsPublished by Elsevier ,1994
- Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian CancerJNCI Journal of the National Cancer Institute, 1993
- In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell lineGynecologic Oncology, 1991
- Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell lineGynecologic Oncology, 1990
- Mechanism by which caffeine potentiates lethality of nitrogen mustard.Proceedings of the National Academy of Sciences, 1982